Oncology

A U.S. and Canada study shows that ASA 300 mg daily does not improve risk of breast cancer recurrence or survival in individuals with high-risk nonmetastatic breast cancer.

How much do you know about the health effects of phytoestrogens?

While increasing age remains a risk factor, researchers found each age group examined saw more diagnoses when comparing data from 1984 to 1988 and 2015 to 2019.

Keytruda and chemotherapy were found to increase median overall survival to 12.9 months, compared with 11.5 months on just chemotherapy.

Key things for primary care providers to remember about prostate cancer surgery recovery.

Though only using a small cohort, a recent study found an algorithm was far better able to predict the likelihood of metastatic progression.

Could this treatment really relegate chemo to the background?

Coalition for Responsible Healthcare Guidelines physicians criticize currency of recommendations from the Canadian Task Force on Preventive Health Care.